MSI2 and B-cell chronic lymphocytic leukemia: In CLL, although high MSI2 levels can correlate with poor outcome [27, 31, 32], there are no studies addressing the function of MSI2 in CLL, how this affects leukemia-cell survival and growth and how this influences clinical outcome in patients or animal models.